HEC CJ PHARM News

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 2 04:39 ET

HEC CJ PHARM: VOLUNTARY ANNOUNCEMENTBECOMING A CONSTITUENT OFHANG SENG FAMILY OF INDEXES

Aug 16 09:25 ET

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 1 04:38 ET

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 3 09:52 ET

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 4 05:22 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

May 21 05:49 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

May 21 05:49 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

May 20 06:25 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

May 20 06:25 ET

HEC CJ PHARM: Special dividend

May 16 05:45 ET

HEC CJ PHARM: Form of Proxy for the Annual General Meeting to be held on Friday, 7 June 2024(or any adjournment thereof)

May 7 07:13 ET

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 04:45 ET

HEC CJ PHARM: 2023 Environmental, Social and Governance Report

Apr 26 10:55 ET

HEC CJ PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 2 05:09 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 21 04:36 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 21 04:36 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 20 04:52 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 20 04:52 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 19 05:08 ET

HEC CJ PHARM: Disclosure of Dealings under Rule 22 of the Takeovers Code

Mar 19 05:08 ET